ENDPOINTS

Scholar Rock aims to raise $275M; Vincerx to reshuffle pipeline focus

7 months ago

News Briefing

Special report 2024: Meet 20 women breaking new ground in biopharma R&D

7 months ago

Special

Galapagos investor gets board seat; OnKure completes merger with Reneo

7 months ago

News Briefing

Editas sells future CRISPR license fees; Plus, news about Oncolytics Biotech

7 months ago

News Briefing

FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum's IPO in South Korea

7 months ago

News Briefing

Biohaven aims to raise $250M; Activist investor's stake in Galapagos exceeds 10%

7 months ago

News Briefing

Repair, Genevant ink deal worth up to $107M; 858 Therapeutics raises $50M

8 months ago

News Briefing

Corrected: Sanofi inks deal with I-Mab spinout; Wave discloses $175M offering on heels of DMD data

8 months ago

News Briefing

Capricor to begin filing DMD drug with FDA next month; Surrozen’s $10M milestone

8 months ago

News Briefing

Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC

8 months ago

News Briefing

Ascendis aims to raise $300M; Basilea inks up to $268M deal with BARDA

8 months ago

News Briefing

Capricor expands DMD pact with Nippon Shinyaku; AbbVie’s new eye deal

8 months ago

News Briefing

Nuvalent's $350M offering; FDA lifts partial hold on Zentalis drug

8 months ago

News Briefing

GSK’s mRNA flu shot is heading to Phase 3; Summit’s $235M offering

8 months ago

News Briefing

Immunovant shares mid-stage Graves’ disease data; FDA lifts Rezolute’s hold

8 months ago

News Briefing

Basilea records $25M milestone; Connect Biopharma reduces workforce in China

8 months ago

News Briefing

Novartis pays $15M upfront to license Voyager program; Boehringer advances geographic atrophy drug

8 months ago

News Briefing

Vaxcyte aims to raise $1B after sharing pneumococcal vaccine data; More layoffs at Genentech

8 months ago

News Briefing

Denali details accelerated approval plans; Jazz's $850M private offering

8 months ago

News Briefing

J&J heads to FDA for Vyvgart competitor; Tokyo conglomerate launches venture fund

8 months ago

News Briefing

SpringWorks gets priority review; Botox competitor data; Hyundai's Covid treatment; Arcus takes a loan

9 months ago

News Briefing

Redalpine closes $200M fund; A base editing pact in China; Merck starts another Phase 3 for Imago drug

9 months ago

News Briefing

Mpox vaccine collab; $11M oncology seed; Gates backs RSV vaccine; Kyowa Kirin slims portfolio

9 months ago

News Briefing

Vandria raises another $10M; Nykode ends Phase 2 trial in cervical cancer

9 months ago

News Briefing

about the author

author articles

Scholar Rock aims to raise $275M; Vincerx to reshuffle pipeline focus

Special report 2024: Meet 20 women breaking new ground in biopharma R&D

Galapagos investor gets board seat; OnKure completes merger with Reneo

Editas sells future CRISPR license fees; Plus, news about Oncolytics Biotech

FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum's IPO in South Korea

Biohaven aims to raise $250M; Activist investor's stake in Galapagos exceeds 10%

Repair, Genevant ink deal worth up to $107M; 858 Therapeutics raises $50M

Corrected: Sanofi inks deal with I-Mab spinout; Wave discloses $175M offering on heels of DMD data

Capricor to begin filing DMD drug with FDA next month; Surrozen’s $10M milestone

Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC

Ascendis aims to raise $300M; Basilea inks up to $268M deal with BARDA

Capricor expands DMD pact with Nippon Shinyaku; AbbVie’s new eye deal

Nuvalent's $350M offering; FDA lifts partial hold on Zentalis drug

GSK’s mRNA flu shot is heading to Phase 3; Summit’s $235M offering

Immunovant shares mid-stage Graves’ disease data; FDA lifts Rezolute’s hold

Basilea records $25M milestone; Connect Biopharma reduces workforce in China

Novartis pays $15M upfront to license Voyager program; Boehringer advances geographic atrophy drug

Vaxcyte aims to raise $1B after sharing pneumococcal vaccine data; More layoffs at Genentech

Denali details accelerated approval plans; Jazz's $850M private offering

J&J heads to FDA for Vyvgart competitor; Tokyo conglomerate launches venture fund

SpringWorks gets priority review; Botox competitor data; Hyundai's Covid treatment; Arcus takes a loan

Redalpine closes $200M fund; A base editing pact in China; Merck starts another Phase 3 for Imago drug

Mpox vaccine collab; $11M oncology seed; Gates backs RSV vaccine; Kyowa Kirin slims portfolio

Vandria raises another $10M; Nykode ends Phase 2 trial in cervical cancer